Kai-Leng Tan

466 total citations
13 papers, 333 citations indexed

About

Kai-Leng Tan is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Kai-Leng Tan has authored 13 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Neurology. Recurrent topics in Kai-Leng Tan's work include Down syndrome and intellectual disability research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Kai-Leng Tan is often cited by papers focused on Down syndrome and intellectual disability research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Kai-Leng Tan collaborates with scholars based in Malaysia, China and Australia. Kai-Leng Tan's co-authors include King‐Hwa Ling, Pike-See Cheah, Han-Chung Lee, Yin Sim Tor, Mengting Yu, Si Chen, Zhengyang Li, Karthik Mallilankaraman, S. Thameem Dheen and Neelima Gupta and has published in prestigious journals such as PLoS ONE, Neuroscience and BMC Genomics.

In The Last Decade

Kai-Leng Tan

13 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai-Leng Tan Malaysia 10 134 56 54 49 46 13 333
Hans Fliri Austria 9 154 1.1× 57 1.0× 29 0.5× 19 0.4× 23 0.5× 19 484
Ken-ichi Nemoto Japan 11 186 1.4× 26 0.5× 41 0.8× 28 0.6× 18 0.4× 19 394
María C. Moreno Argentina 14 233 1.7× 37 0.7× 20 0.4× 18 0.4× 16 0.3× 25 520
Lynn Ulatowski United States 13 268 2.0× 23 0.4× 20 0.4× 45 0.9× 21 0.5× 20 589
Nicola Salvatore Orefice Italy 12 200 1.5× 15 0.3× 12 0.2× 29 0.6× 64 1.4× 21 359
Ioannis Patrikios Cyprus 10 116 0.9× 45 0.8× 20 0.4× 16 0.3× 15 0.3× 23 336
F. Alexandra Loucks United States 10 301 2.2× 17 0.3× 43 0.8× 23 0.5× 14 0.3× 12 536
Özlem Dalmızrak Cyprus 10 230 1.7× 27 0.5× 20 0.4× 9 0.2× 41 0.9× 27 408
Sonia Salzano Italy 4 222 1.7× 14 0.3× 50 0.9× 22 0.4× 11 0.2× 5 403
Domenico Fazio Italy 6 131 1.0× 13 0.2× 17 0.3× 15 0.3× 34 0.7× 11 380

Countries citing papers authored by Kai-Leng Tan

Since Specialization
Citations

This map shows the geographic impact of Kai-Leng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai-Leng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai-Leng Tan more than expected).

Fields of papers citing papers by Kai-Leng Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai-Leng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai-Leng Tan. The network helps show where Kai-Leng Tan may publish in the future.

Co-authorship network of co-authors of Kai-Leng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Kai-Leng Tan. A scholar is included among the top collaborators of Kai-Leng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai-Leng Tan. Kai-Leng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Li, Zhengyang, et al.. (2023). Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains. Biomedicine & Pharmacotherapy. 158. 114206–114206. 29 indexed citations
2.
Tan, Kai-Leng, Han-Chung Lee, Pike-See Cheah, & King‐Hwa Ling. (2022). Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy. Neuroscience. 511. 1–12. 21 indexed citations
3.
Gupta, Neelima, et al.. (2020). miR-142-3p Regulates BDNF Expression in Activated Rodent Microglia Through Its Target CAMK2A. Frontiers in Cellular Neuroscience. 14. 132–132. 30 indexed citations
4.
Chen, Si, et al.. (2020). Enhanced Contextual Fear Memory and Elevated Astroglial Glutamate Synthase Activity in Hippocampal CA1 BChE shRNA Knockdown Mice. Frontiers in Psychiatry. 11. 564843–564843. 5 indexed citations
5.
Goh, Bey Hing, et al.. (2020). ‘Sweeter’ than its name: anti-inflammatory activities of Stevia rebaudiana. All Life. 13(1). 286–309. 16 indexed citations
6.
Huang, Su-Hua, et al.. (2019). The potential of MLC901 (NeuroAiD II™), a traditional Chinese medicine. 2(2). 18–24. 1 indexed citations
7.
Lee, Han-Chung, Kai-Leng Tan, Pike-See Cheah, & King‐Hwa Ling. (2016). Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain. Neural Plasticity. 2016. 1–12. 36 indexed citations
8.
Tan, Kai-Leng, King‐Hwa Ling, Chelsee Hewitt, et al.. (2014). Transcriptional profiling of the postnatal brain of the Ts1Cje mouse model of Down syndrome. Genomics Data. 2. 314–317. 2 indexed citations
9.
Tan, Kai-Leng, et al.. (2014). Harvesting the maximum length of sciatic nerve from adult mice: a step-by-step approach. BMC Research Notes. 7(1). 714–714. 23 indexed citations
10.
Ling, King‐Hwa, Chelsee Hewitt, Kai-Leng Tan, et al.. (2014). Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks. BMC Genomics. 15(1). 624–624. 52 indexed citations
11.
Tan, Kai-Leng, et al.. (2013). MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome. Frontiers in Cellular Neuroscience. 7. 41–41. 35 indexed citations
12.
Tan, Kai-Leng, et al.. (2012). Chemopreventive Potential of Annona Muricata L Leaves on Chemically-Induced Skin Papillomagenesis in Mice. Asian Pacific Journal of Cancer Prevention. 13(6). 2533–2539. 66 indexed citations
13.
Chu, Qin, et al.. (2012). What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?. PLoS ONE. 7(11). e49969–e49969. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026